Abstract: This invention relates to the use of zinc gluconate for making a medicament administered by the oral route and containing from 50 to 150 mg of zinc gluconate, said medicament being used for the treatment of hyperprolactinaemias.
Type:
Grant
Filed:
December 3, 1985
Date of Patent:
October 21, 1986
Assignee:
501 Societe Civile de Recherches et d'Etudes Theraputiques